Advisory Board
Dr. Rogelio González
Oncologist
Dr. José Rogelio González Ramírez Benfield is a molecular oncologist specializing in the integration of AI in healthcare, based in Guadalajara, Mexico. He currently serves as Chief Operative Officer at Quantum Frontier Technologies and as a clinical oncologist at Anker Oncología Global. Additionally, he is a scientific advisor at the Fundación de Voluntarias Contra el Cáncer and has been the principal investigator in over 23 clinical trials. His experience includes roles at the Instituto Jalisciense de Cancerología and the Cancer Treatment Centers of America. Academically, he holds a specialty in AI in healthcare systems from Stanford, and has studied molecular oncology, precision medicine, and pharmacoeconomics at several prestigious institutions in Mexico.
Sandra Owens
Clinical Trials Advisor
More than 20 years of experience in oncology, in the development of immunotherapies, biological products and specific agents that require diagnostics for an early and successful launch in the market of the arid and semi-arid zones and Asia-Pacific, both in R&D and in generic product markets. An effective leader with a proven ability to build a high performing team and deliver strong P&L performance, Sandra has achieved this in both large commercial groups and specialist business units at AstraZeneca, Sanofi Aventis, Merck Serono and Alphapharm/Mylan.
Dra. María del Mar Luque
Intensive Care Medicine
Dr. María del Mar Luque Fernández, a graduate in Medicine and Surgery from the University of Málaga, is a specialist in Intensive Care Medicine, Regenerative Medicine, and Medical Genetics. She holds a postgraduate degree in Physiological Aging Medicine and a master’s in Traditional Chinese Acupuncture and Moxibustion, showcasing her versatility across various medical fields. Currently, she is a professor at the Virgen de La Paz Nursing School in Ronda, affiliated with the University of Málaga. With over 25 years of experience in the Andalusian Health Service and leadership roles in international institutions like Adventum and the European Advanced Medicine Hospital, Dr. Luque has authored more than 30 scientific articles and several book chapters, solidifying her reputation in the medical field.
Dr. Iván Romarico
Oncologist
Dr. Iván Romarico González Espinoza is a medical oncologist with over 18 years of experience at Hospital Ángeles in Puebla, Mexico. He holds a Master's degree in Molecular Oncology and another in Molecular Bases of Cancer, both from the Spanish National Cancer Research Center. He completed his specialties in Internal Medicine and Medical Oncology at the National Institute of Medical Sciences and Nutrition Salvador Zubirán. Additionally, he earned his Medical Doctor degree from the University of Guadalajara. His extensive education and experience in oncology and cancer biology make him a distinguished expert in his field, with a notable track record in the care and treatment of oncology patients.
Rose Brown
Clinical Trials Advisor
Over 20 years of experience at large pharmaceutical companies, including Eli Lilly & Sanofi Aventis, and works with a solutions-focused attitude to overcome key challenges and drive business results with quality results. Rose has a proven track record in developing new products and clinical programs, including designing innovative trials, from phase I to phase IV.
Belinda Hartmann
Consejera de Patentes
Accomplished scientist, with a Ph.D. in bioengineering and biotechnology. She was a CSIRO Postdoctoral Fellow, before leaving the lab to complete her master's degree in intellectual property on her way to becoming a registered patent attorney in Australia and New Zealand.
Belinda has worked for two of Australia's largest IP firms, where she gained invaluable experience providing clients with exceptional service throughout the life of a patent.
We lead the Precision Medicine biomedical revolution
This represents a huge opportunity for both patients and the sector in terms of economics and innovation